Characterization of cancer‐associated fibroblasts and their spatial architecture reveals heterogeneity and survival associations in classic Hodgkin lymphoma
Cancer-associated fibroblasts (CAFs) are a heterogeneous population of stromal cells, which modulate the immune system and can have both pro- and anti-tumorigenic effects. In classic Hodgkin lymphoma (cHL), the role of CAFs has remained largely undefined. We applied multiplexed immunofluorescence imaging and spatial analysis on tumor samples from two independent cHL patient cohorts (<i>n</i> = 131 and <i>n</i> = 148) to study CAFs and their interactions with Hodgkin Reed-Sternberg (HRS) and tumor microenvironment (TME) cells at the single-cell resolution. We show that higher proportions of CAFs are associated with favorable outcomes, independent of the clinical covariables. In contrast, a subset of CD45<sup>+</sup> immune cells with strong fibroblast-activation protein positivity, classified as macrophages, was less abundant in nodular sclerosis subtype and associated with worse outcomes. Neighborhood analysis allowed for the identification of colocalization or regional exclusion of phenotypically defined cell types and recurrent cellular neighborhoods. Despite the positive impact of CAF proportions on survival, patients with enrichment of platelet-derived growth factor receptor beta (PDGFRB)-positive CAFs in the vicinity of HRS cells had worse survival in both cohorts, independent of the clinical determinants. Our findings distinguish various subsets of CAFs and macrophages impacting survival in cHL and underscore the importance of the spatial arrangements in the TME.
Authors
- Teijo Pellinen (ORCID: https://orcid.org/0000-0001-9652-7373)
- Kristiina Karihtala (ORCID: https://orcid.org/0000-0002-8807-8624)
- Christian Steidl (ORCID: https://orcid.org/0000-0001-9842-9750)
- Sirpa Leppä (ORCID: https://orcid.org/0000-0002-8265-511X)
- Marja‐Liisa Karjalainen‐Lindsberg (ORCID: https://orcid.org/0000-0001-6728-2266)
- Tomohiro Aoki (ORCID: https://orcid.org/0000-0001-6782-8361)
- Suvi‐Katri Leivonen (ORCID: https://orcid.org/0000-0003-3224-0757)
Institutions
- University Health Network (CA)
- University of Helsinki (FI)
- Helsinki University Hospital (FI)
- Spinal Cord Injury BC (CA)
- Princess Margaret Cancer Centre (CA)
- Institute for Molecular Medicine Finland (FI)
Publication Details
- Journal
- HemaSphere
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1002/hem3.70145
- Citations
- 1
- Primary Topic
- Single-cell and spatial transcriptomics
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Helsingin Yliopisto
- Helsingin ja Uudenmaan Sairaanhoitopiiri
- Academy of Finland